Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We evaluated the risk of cardiovascular (CV) death in all Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) study participants and in those who experienced an on-study, major nonfatal CV event.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Diabetes Care

Title: Diabetes care

Publisher: American Diabetes Association

ISSN (Electronic): 1935-5548

ISSN (Print): 0149-5992

Publication date (Electronic): Jul 2016

Volume: 39

Issue: 7

Affiliations

[1 ] University of Connecticut School of Medicine, Farmington, CT wwhite@uchc.edu.

[2 ] Takeda Development Center Americas, Inc., Deerfield, IL.

[3 ] INSERM 9501, Universite de Lorraine and CHU, Nancy, France.

[4 ] Harvard School of Public Health, Boston, MA.

[5 ] Harvard Clinical Research Institute, Boston, MA.

[6 ] The University of Chicago Medicine, Chicago, IL.

[7 ] Cleveland Clinic Foundation, Cleveland, OH.

[8 ] The University of Tennessee Health Science Center College of Medicine, Memphis VA Medical Center, Memphis, TN.

[9 ] University of Sheffield, Sheffield, U.K.

[10 ] International Diabetes Center, Park-Nicollet Clinic, Minneapolis, MN.

[11 ] Harvard Clinical Research Institute, Boston, MA Harvard Medical School, Boston, MA.

Article

Publisher Item ID: dc16-0303

DOI: 10.2337/dc16-0303

PubMed ID: 27289121

SO-VID: acd59173-e3db-48c7-8553-9c52807ee049

History

Data availability:

Comments

Comment on this article

scite_

Cited by 22

See all cited by